Novavax Makes Big Move Donating 1.1 Billions Doses to Serum Institute of India as part of COVAX Deal
Novavax Inc. (Nasdaq: NVAX) inked a Memorandum of Understanding (MOU) with Gavi, the Vaccine Alliance (Gavi), to supply up to […]
Novavax Inc. (Nasdaq: NVAX) inked a Memorandum of Understanding (MOU) with Gavi, the Vaccine Alliance (Gavi), to supply up to […]
Military and connected beneficiaries of Fort Bragg’s Military Health System and Tricare can lend a hand to help the biomedical […]
Affiliated with Brown University, Rhode Island Hospitals and Health Services also known as Lifespan now seeks to enroll volunteers for […]
One of the first physician/investigators to distribute the Novavax vaccine in the recently launched Phase 3 clinical trial was showcased […]
Led by Principal Investigator Dr. Scott McClelland and Dr. Anna Wald, the University of Washington School of Medicine (UW Medicine) […]
The University of Iowa Health Care (UIHC) gains a more prominent role as a trial site hub investigating COVID-19 investigational […]
Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today provided an update on its […]
What does a niche vaccine-focused biotech from Gaithersburg, MD toiling in relative obscurity for years and a small Native American […]
Back in August, the UK and American vaccine maker Novavax announced an agreement to proceed to a Phase 3 clinical […]
Novavax Inc. (Nasdaq: NVAX) has progressed their investigational vaccine product for COVID-19 called NVX-CoV2373 to Phase 3 to evaluate the […]